Macular Degeneration Completed Phase 1 Trials for Faricimab (DB15303)
Also known as: Macula lutea degeneration / Retinal macula lutea degeneration / Macular luteal degeneration / Degenerative disorder of macula (disorder) / Degeneration macular
| Indication | Status | Phase |
|---|---|---|
| DBCOND0027875 (Macular Degeneration) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01941082 | A Study of RO6867461 Administered in Single- and Multiple-Ascending Doses in Patients With Wet Age-Related Macular Degeneration | Treatment |